HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.

Abstract
Two bispecific recombinant molecules, an anti-CD3 x anti-carcinoembryogenic antigen (CEA) diabody and a B7 x anti-CEA fusion protein, were tested for their capacity to specifically activate T cells in the presence of CEA-expressing colon carcinoma cells. T-cell activation by the anti-CD3 x anti-CEA diabody required close contact to CEA-positive cells and resulted in diabody-mediated cytotoxicity against the target cells. Additionally, CD28-mediated costimulation in combination with anti-CD3 x anti-CEA diabodies induced activation of autologous T cells in CEA-positive primary colon carcinoma specimens, as determined by flow cytometry. The high specificity of the bispecific diabody approach could be further enhanced by the use of B7 x anti-CEA fusion proteins because the costimulatory CD28-signaling to the T cells strictly depended on the expression of CEA on the target cells. We demonstrate that displaying engagement sites for the T-cell antigens CD3 and CD28 on the surface of colon carcinoma cells is a suitable way to activate and retarget T cells in a highly tumor-specific manner. For clinical purposes, B7 x anti-tumor-associated antigen (TAA) fusion proteins, which are equally effective but more specific compared with anti-CD28 monoclonal anti-bodies, thus may improve the tumor specificity of anti-CD3 x anti-TAA bispecific antibodies. Furthermore, B7-negative tumors can be converted into B7-positive tumors by B7 x anti-TAA fusion proteins without the need for B7 gene transfer to the malignant cells.
AuthorsP Holliger, O Manzke, M Span, R Hawkins, B Fleischmann, L Qinghua, J Wolf, V Diehl, O Cochet, G Winter, H Bohlen
JournalCancer research (Cancer Res) Vol. 59 Issue 12 Pg. 2909-16 (Jun 15 1999) ISSN: 0008-5472 [Print] United States
PMID10383154 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bispecific
  • B7-1 Antigen
  • CD28 Antigens
  • CD3 Complex
  • Carcinoembryonic Antigen
  • DNA Primers
  • Recombinant Fusion Proteins
Topics
  • Amino Acid Sequence
  • Antibodies, Bispecific (biosynthesis, immunology)
  • B7-1 Antigen (immunology)
  • CD28 Antigens (immunology)
  • CD3 Complex (immunology)
  • Carcinoembryonic Antigen (immunology)
  • Colonic Neoplasms (chemically induced, immunology)
  • Cytotoxicity, Immunologic
  • DNA Primers
  • Humans
  • Lymphocyte Activation
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Molecular Sequence Data
  • Recombinant Fusion Proteins (immunology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: